Feature | September 01, 2010

Heart Rhythm Society Study Shows Increasing EP Demand

September 1, 2010 – A new study on overall workforce trends in the field of cardiac electrophysiology (EP) reveals an increasing demand for EP professionals as a result of shifting demographic trends, evolving health reform policies and improved procedural outcomes. The comprehensive workforce study published in the September issue of the HeartRhythm Journal, the official journal of the Heart Rhythm Society, found substantial growth in the overall volume and complexity of cardiac procedures performed in the past decade.

The study, commissioned in 2009 by the Heart Rhythm Society, provides data from nearly 700 respondents, including EPs, allied professionals and basic scientists currently working within the field of cardiac electrophysiology. The median age of physician respondents was 50 years with the majority falling between 46 and 55 years of age. While the average work week for physician respondents is 60 hours, nearly 30 percent work between 61 and 75 hours a week. For every respondent age-range queried the workload is expected to increase over the next five years for EPs, allied professionals and basic scientists alike.

“The field of cardiac electrophysiology continues to evolve as physicians are faced with new challenges in a changing healthcare environment,” said lead author Thomas F. Deering, M.D., FHRS, CCDS, Piedmont Heart Institute in Atlanta, Ga. “As seen from this study, electrophysiologists must embrace the advancements in technology and adapt to the changes in healthcare reform in order to continue to deliver high-quality care to a growing patient population.”

Work Capacity
Study results found that most physicians anticipate an increased workload in response to several key factors, including an aging patient population, broader access to care, possible expansion in indications for specific therapies (such as device implantation and ablation procedures), increasingly complex procedures and a potentially decreasing workforce as the current workforce gets older, cuts their hours and/or retires.

Approximately one quarter of physicians are highly specialized in the type of procedural work they perform with 25 percent of the physician respondents spending more than 85 percent of their procedural work time on either device or ablation procedures. In general, practice time is predominantly spent on device implantations, device follow-up and ablations. Some of these activities, such as complex device or ablation procedures, are being tasked to younger physicians indicating a growing need for more well-trained allied professionals to assume a greater role in device management. Furthermore, nearly two-thirds of all respondents are currently at or exceeding their perceived workload capacity for device therapies and catheter ablation.

Device Implantation, Follow-Up
More than 55 percent of the physician respondents indicated that the total number of implantation procedures they performed each year compared to five years ago had increased. Additionally, the follow-up of implanted devices was the largest percentage of activity reported, on average more than 200 performed annually per respondent. Currently, allied professionals play a significant role in managing device patient follow-up, and this need will steadily increase as the number of device patients continues to rise. Overall, device implantation accounts for nearly one-fourth of the survey respondent’s workweek. And, pacemaker and implantable cardioverter-defibrillator (ICD) implantations are performed equally by physician respondents of all ages; whereas, cardiac resynchronization therapy (CRT) device implantation is more common among young or mid-career physicians.

Ablation Procedures
According to the study, the median proportion of time each respondent spends on ablation procedures during the workweek is 15.8 percent. Supraventricular tachycardia (SVT) procedures were the most common – with 76.9 percent of survey respondents having performed an SVT in the last 12 months. SVT ablation became less common as the age range of respondents increased. Like SVT ablations, older respondents were less likely to perform VT ablations. Atrial fibrillation (AF) ablation was performed less often. In general, the survey found AF and VT ablation are almost exclusively performed by early and mid-career physicians.

“Building a steady pipeline of emerging EPs, meeting the educational and training needs of allied professionals and fostering the growth of basic science is critically important as the demand for cardiac electrophysiology continues to grow,” Deering said.

For more information: www.heartrhythmjournal.com

Related Content

HRS study finds Frequent Coffee Consumption Lowers Chance of Arrhythmias. #HRS #HRS20 Heartrhythm20
News | EP Lab | May 28, 2020
May 28, 2020 – A recent study revealed that drinking a couple of cups of coffee per day does not lead to a greater ri
he Actus AcQMap EP 3-D mapping catheter used  to speed  electromapping and procedure times.

he Actus AcQMap EP 3-D mapping catheter used  to speed  electromapping and procedure times.

News | EP Lab | May 20, 2020
May 20, 2020 — Acutus Medical and Biotronik announced a new alliance to provide a comprehensive portfolio of...
Thermedical, a developer of thermal-ablation medical systems to treat ventricular tachycardia (VT), announced that it has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Saline Enhanced Radiofrequency (SERF) Ablation system and Durablate catheter.
News | EP Lab | May 19, 2020
May 19, 2020 – Thermedical, a developer of thermal-ablation medical systems to treat ventricular tachycardia (VT), an
HRS presentations included BlueSync Evaluation study for Medtronic MyCareLink Heart mobile app and Micra TPS CED Study
News | EP Lab | May 14, 2020
May 14, 2020 – Medtronic announced results from late-breaking clinical trials evaluating the MyCareLink Heart mobile
Etripamil Nasal Spray Does Not Meet Primary Endpoint in Treating Supraventricular Tachycardia in the NODE-301 trial presented at Heart Rhythm 2020. #heartrhythm2020 #HRS2020
News | EP Lab | May 13, 2020
May 13, 2020 — The patient-administered nasal spray drug etripamil did not meet its primary endpoint in treating pati
Medtronic Cobalt and Crome ICD
News | EP Lab | May 12, 2020
May 12, 2020 — Medtronic has received U.S.
The CardioFocus HeartLight Excalibur Balloon X3 ablation system allows direct visualization of the laser ablation procedure, helping reduce use of X-ray angiography and reducing procedure time. FDA clears, approved, the HeartLight X3 Laser Ablation System to Treat Atrial Fibrillation.

The CardioFocus HeartLight Excalibur Balloon X3 ablation system allows direct visualization of the laser ablation procedure, helping reduce use of X-ray angiography and reducing procedure time.

News | EP Lab | May 12, 2020
May 12, 2020 — The U.S. Food and Drug Administration (FDA) has cleared the next-generation CardioFocus Inc.
EP lab photo from Philips Healthcare
News | EP Lab | April 30, 2020
May 1, 2020 — The Heart Rhythm Society (HRS) has created a COVID-19 Task Force to make recommendations related to edu
The European Heart Rhythm Association (EHRA) electrophysiology (EP) annual meeting cancelled due to coronavirus. #COVID19 #coronavirus #2019nCoV
Feature | EP Lab | March 10, 2020 | Dave Fornell, Editor
March 10, 2020 — Novel coronavirus (...
The U.S. Food and Drug Administration (FDA) cleared the Acutus Medical SuperMap, an addition to its AcQMap 3-D imaging and mapping system used to guide electrophysiology (EP) catheter ablation procedures. Adding the SuperMap mode to the AcQMap system enables users to visualize any atrial rhythm in less than three minutes. Rapidly mapping and re-mapping the whole heart chamber facilitates a new procedural workflow in EP ablation, making it practical to execute an iterative "map, ablate, re-map" approach.
News | EP Lab | March 05, 2020
March 5, 2020 — The U.S.